AstraZeneca wants some fresh eyes on its financial challenges. The drug maker is casting outside of pharma for a new CFO to replace Jon Symonds, who quit abruptly in June to join Goldman Sachs.
The company is down to a short list and expects to announce the chosen one soon. That'll be two down and five to go; Pfizer recently tapped an industry outsider as its new CFO, and five other drug companies are still on the hunt.
- read this article from the Financial Times
Finance chiefs fleeing from biopharmas. Report
AstraZeneca cuts 7,600 jobs. Report
AstraZeneca announces restructuring and buyout. Report
AstraZeneca to continue ambitious deal-making. Report
AstraZeneca lays out road map for recovery. Report